The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
Ginger—An Herbal Medicinal Product with Broad Anti-Inflammatory Actions
Abstract
The anti-inflammatory properties of ginger have been known and valued for centuries. During the past 25 years, many laboratories have provided scientific support for the long-held belief that ginger contains constituents with antiinflammatory properties. The original discovery of ginger's inhibitory effects on prostaglandin biosynthesis in the early 1970s has been repeatedly confirmed. This discovery identified ginger as an herbal medicinal product that shares pharmacological properties with non-steroidal anti-inflammatory drugs. Ginger suppresses prostaglandin synthesis through inhibition of cyclooxygenase-1 and cyclooxygenase-2. An important extension of this early work was the observation that ginger also suppresses leukotriene biosynthesis by inhibiting 5-lipoxygenase. This pharmacological property distinguishes ginger from nonsteroidal anti-inflammatory drugs. This discovery preceded the observation that dual inhibitors of cyclooxygenase and 5-lipoxygenase may have a better therapeutic profile and have fewer side effects than non-steroidal anti-inflammatory drugs. The characterization of the pharmacological properties of ginger entered a new phase with the discovery that a ginger extract (EV.EXT.77) derived from Zingiber officinale (family Zingiberaceae) and Alpina galanga (family Zingiberaceae) inhibits the induction of several genes involved in the inflammatory response. These include genes encoding cytokines, chemokines, and the inducible enzyme cyclooxygenase-2. This discovery provided the first evidence that ginger modulates biochemical pathways activated in chronic inflammation. Identification of the molecular targets of individual ginger constituents provides an opportunity to optimize and standardize ginger products with respect to their effects on specific biomarkers of inflammation. Such preparations will be useful for studies in experimental animals and humans.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inhibition of Prostaglandin Synthesis as a Mechanism of Action for Aspirin-like Drugs
VANE, J. R. (1971) · Nature New Biology · doi:10.1038/newbio231232a0 · Cited by 8,605
Inflammation and Alzheimer’s disease
Akiyama, H. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00124-x · Cited by 4,514
Microglia: a sensor for pathological events in the CNS
Kreutzberg, G. W. (1996) · Trends in Neurosciences · doi:10.1016/0166-2236(96)10049-7 · Cited by 4,396
NF-κB: a key role in inflammatory diseases
Tak, P. P., & Firestein, G. S. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11830 · Cited by 3,918
Vane, J. R., Bakhle, Y. S., & Botting, R. M. (1998) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.38.1.97 · Cited by 2,734
Cytokine Pathways and Joint Inflammation in Rheumatoid Arthritis
Choy, E. H. S., & Panayi, G. S. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103223441207 · Cited by 2,249
Inhibition of NF-κB by Sodium Salicylate and Aspirin
Kopp, E., & Ghosh, S. (1994) · Science · doi:10.1126/science.8052854 · Cited by 1,753
Surh, Y.-J., Chun, K.-S., Cha, H.-H., Han, S. S., Keum, Y.-S., Park, K.-K., & Lee, S. S. (2001) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/s0027-5107(01)00183-x · Cited by 1,620
Therapeutic potential of inhibition of the NF-κB pathway in the treatment of inflammation and cancer
Yamamoto, Y., & Gaynor, R. B. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11914 · Cited by 1,585
Nonsteroidal Antiinflammatory Drugs and the Risk of Alzheimer's Disease
in 't Veld, B. A., Ruitenberg, A., Hofman, A., Launer, L. J., van Duijn, C. M., Stijnen, T., Breteler, M. M. B., & Stricker, B. H. C. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa010178 · Cited by 1,196
Cited by
Ali, B. H., Blunden, G., Tanira, M. O., & Nemmar, A. (2008) · Food and Chemical Toxicology · doi:10.1016/j.fct.2007.09.085 · Cited by 1,588
Zhang, M., Viennois, E., Prasad, M., Zhang, Y., Wang, L., Zhang, Z., Han, M. K., Xiao, B., Xu, C., Srinivasan, S., et al. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.06.018 · Cited by 1,026
Health benefits of herbs and spices: the past, the present, the future
Tapsell, L. C., Hemphill, I., Cobiac, L., Sullivan, D. R., Fenech, M., Patch, C. S., Roodenrys, S., Keogh, J. B., Clifton, P. M., Williams, P. G., et al. (2006) · Medical Journal of Australia · doi:10.5694/j.1326-5377.2006.tb00548.x · Cited by 988
Anti-Inflammatory Drugs in the 21st Century
Rainsford, K. D. (2007) · Subcellular Biochemistry · doi:10.1007/1-4020-5688-5_1 · Cited by 463
Ginger and Its Constituents: Role in Prevention and Treatment of Gastrointestinal Cancer
Prasad, S., & Tyagi, A. K. (2015) · Gastroenterology Research and Practice · doi:10.1155/2015/142979 · Cited by 439
Eslamparast, T., Poustchi, H., Zamani, F., Sharafkhah, M., Malekzadeh, R., & Hekmatdoost, A. (2014) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.113.068890 · Cited by 405
B. Aggarwal, B., Prasad, S., Reuter, S., Kannappan, R., R. Yadav, V., Park, B., Hye Kim, J., C. Gupta, S., Phromnoi, K., Sundaram, C., et al. (2011) · Current Drug Targets · doi:10.2174/138945011798109464 · Cited by 368
Zick, S. M., Djuric, Z., Ruffin, M. T., Litzinger, A. J., Normolle, D. P., Alrawi, S., Feng, M. R., & Brenner, D. E. (2008) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-07-2934 · Cited by 335
The response of fish to immunostimulant diets
Vallejos-Vidal, E., Reyes-López, F., Teles, M., & MacKenzie, S. (2016) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2016.06.028 · Cited by 334
Plant-derived extracellular vesicles: a novel nanomedicine approach with advantages and challenges
Nemati, M., Singh, B., Mir, R. A., Nemati, M., Babaei, A., Ahmadi, M., Rasmi, Y., Golezani, A. G., & Rezaie, J. (2022) · Cell Communication and Signaling · doi:10.1186/s12964-022-00889-1 · Cited by 307
Update on the Chemopreventive Effects of Ginger and its Phytochemicals
Baliga, M. S., Haniadka, R., Pereira, M. M., D’Souza, J. J., Pallaty, P. L., Bhat, H. P., & Popuri, S. (2011) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408391003698669 · Cited by 294
A review of the gastroprotective effects of ginger (Zingiber officinale Roscoe)
Haniadka, R., Saldanha, E., Sunita, V., Palatty, P. L., Fayad, R., & Baliga, M. S. (2013) · Food & Function · doi:10.1039/c3fo30337c · Cited by 249
Antioxidant/lipoxygenase inhibitory activities and chemical compositions of selected essential oils
Wei, A., & Shibamoto, T. (2010) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf101077s · Cited by 241
Ginger on Human Health: A Comprehensive Systematic Review of 109 Randomized Controlled Trials
Anh, N. H., Kim, S. J., Long, N. P., Min, J. E., Yoon, Y. C., Lee, E. G., Kim, M., Kim, T. J., Yang, Y. Y., Son, E. Y., et al. (2020) · Nutrients · doi:10.3390/nu12010157 · Cited by 227
Ginger in gastrointestinal disorders: A systematic review of clinical trials
Nikkhah Bodagh, M., Maleki, I., & Hekmatdoost, A. (2019) · Food Science & Nutrition · doi:10.1002/fsn3.807 · Cited by 221
Jafarzadeh, A., & Nemati, M. (2018) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2018.09.003 · Cited by 84
Geck, M. S., Cristians, S., Berger-González, M., Casu, L., Heinrich, M., & Leonti, M. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.01160 · Cited by 74
van Tilburg, M. A. L., Palsson, O. S., Ringel, Y., & Whitehead, W. E. (2014) · Complementary Therapies in Medicine · doi:10.1016/j.ctim.2013.12.015 · Cited by 64
Drozdov, V. N., Kim, V. A., Tkachenko, E. V., & Varvanina, G. G. (2012) · The Journal of Alternative and Complementary Medicine · doi:10.1089/acm.2011.0202 · Cited by 55
Ebrahimzadeh Attari, V., Asghari Jafarabadi, M., Zemestani, M., & Ostadrahimi, A. (2015) · Phytotherapy Research · doi:10.1002/ptr.5343 · Cited by 42
Nutraceuticals and skin health: Key benefits and protective properties
Pearson, K. (2018) · Journal of Aesthetic Nursing · doi:10.12968/joan.2018.7.sup1.35 · Cited by 14
Metadata
- Authors
- Grzanna, R., Lindmark, L., & Frondoza, C. G.
- Venue
- Journal of Medicinal Food
- Publisher
- SAGE Publications
- Published
- 2005-06
- Volume
- 8
- Issue
- 2
- Pages
- 125-132
- ISSN
- 1096-620X (ISSN-L)
- 1557-7600
- OpenAlex
- W1982523260
- Cited by
- 778
- References
- 63
- FWCI
- 8.96
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.